- Digital Science named SciSwipe and SciFlow as the latest winners of its prestigious Catalyst Grant. The award offers up to £25,000 ($30,000) for concepts with the potential to transform scientific and academic research (1).
- Digital Science named SciSwipe and SciFlow as the latest winners of its prestigious Catalyst Grant. The award offers up to £25,000 ($30,000) for concepts with the potential to transform scientific and academic research (1).
- Dutch biotech company Toxys raises €2 million financing for the global expansion of its animal-free safety testing for novel medicines, chemicals, cosmetics, and food. Toxys will also use the funding to speed-up implementation of its toxicology assays for regulatory applications (2).
- Agilent Technologies has announced a partnership with Visiopharm to ensure standardized cancer diagnosis using artificial intelligence-driven solutions. It is hoped the comarketing relationship will lead to offering that accelerate diagnoses for patients (3).
- The FDA has issued an emergency use authorization for a Thermo Fisher Scientific’s diagnostic test for SARS-CoV-2 – the virus that causes COVID-19. The test uses Applied Biosystems TaqPath Assay technology and is designed to provide patient results within four hours (4).
- Tasso Inc has completed a $6.1 million financing round led by Vertical Venture Partners, with participation from Techstars and Cedars-Sinai. The funding will help Tasso scale its first product, Tasso OnDemand, a patient-centric sampling platform featured in our 2019 Innovation Awards, and grow their team to support significant commercial interest (5).
Newsletters
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
References
- Digital Science (2020). Available at: https://bit.ly/2UPjKJf
- Toxys (2020). Available at: https://bit.ly/3dNpf3w
- Business Wire (2020). Available at: https://bwnews.pr/2X17LLs
- Thermo Fisher (2020). Available at: https://bit.ly/342j9bg
- Vertical Venture Partners (2020). Available at: https://bit.ly/3aAND6y
